Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 42708-054

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 42708-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00093738556

Venlafaxine Hydrochloride 75 mg extended release oral capsules depicted. The capsules are beige and oblong-shaped with imprint "93 7385" on one side. The image includes a millimeter scale for size reference. No manufacturer or NDC code visible on the capsules themselves.*

FDA Label Image

Figure 1 (Venlafaxine HCl Er Caps A076565 1)

A pharmacokinetic (PK) fold change graph showing drug interaction effects on venlafaxine. The chart plots the change relative to reference values for Cmax and AUC parameters with 90% confidence intervals. Interacting drugs listed include ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. Recommendations such as dose adjustment advice and cautions based on interaction are noted.*

FDA Label Image

Figure 2 (Venlafaxine HCl Er Caps A076565 2)

A pharmacokinetic interaction graph showing fold changes in Cmax and AUC values for various interacting drugs when coadministered with venlafaxine hydrochloride. The chart includes drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium with recommendations ranging from no dose adjustment to avoiding concomitant use.*

FDA Label Image

Figure 3 (Venlafaxine HCl Er Caps A076565 3)

A scatter plot chart showing the fold change and 90% confidence interval of pharmacokinetic parameters (Cmax, AUC) for venlafaxine and its metabolite ODV across various special populations, including hepatic and renal impairment, CYP2D6 polymorphism, age over 60 years, and gender. Recommendations for dose adjustments based on these changes are listed alongside.*

FDA Label Image

Structural Formula For Venlafaxine Hydrochloride (Venlafaxine HCl Er Caps A076565 4)

Chemical structure of venlafaxine hydrochloride showing the molecular arrangement including a methoxyphenyl group, a cyclohexanol moiety, and a dimethylaminoethyl side chain, associated with hydrochloride (HCl).*

FDA Label Image

42708-054-30 Venlafaxine Hydrochloride Extended-release Capsules Usp 75mg X 30 (Venlafaxine HCl Er Caps A076565 6)

Label for Venlafaxine Hydrochloride extended-release capsules USP, 75 mg, containing 30 tablets. The label indicates the product is distributed by QPharma, Inc., Cedar Knolls, NJ. It includes instructions for dosage placeholders and storage at controlled room temperature. Marked as a sample not for sale and Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.